Dose-Response: An International Journal
Volume 12 | Issue 1

Article 12

3-2014

OBITUARY: MYRON POLLYCOVE
Ludwig E. Feinendegen
Jerry M. Cuttler

Follow this and additional works at: https://scholarworks.umass.edu/dose_response
Recommended Citation
Feinendegen, Ludwig E. and Cuttler, Jerry M. (2014) "OBITUARY: MYRON POLLYCOVE," Dose-Response: An International Journal:
Vol. 12 : Iss. 1 , Article 12.
Available at: https://scholarworks.umass.edu/dose_response/vol12/iss1/12

This News Article is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Dose-Response:
An International Journal by an authorized editor of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.

Feinendegen and Cuttler: OBITUARY: MYRON POLLYCOVE

Dose-Response, 12:166–169, 2014
Formerly Nonlinearity in Biology, Toxicology, and Medicine
Copyright © 2014 University of Massachusetts
ISSN: 1559-3258
DOI: 10.2203/dose-response.13-058.Feinendegen

OBITUARY: MYRON POLLYCOVE

Ludwig E. Feinendegen and Jerry M. Cuttler, December 2013

Myron Pollycove was born in Arizona and died on August 4, 2013 in
San Francisco, near his children, at the age of 92. He leaves many feeling
sad at having lost a wonderful friend. He also leaves a multifaceted range
of seminal achievements, highlighted by the use of radiotracers in clinical medicine and his attribution of the benefits and risks of a low dose of
ionizing radiation to its effects on the adaptive protection systems.
In 1942, Myron began training in physics and mathematics at the
California Institute of Technology (CALTEC). From 1942 to 1946, he
served in WW II as a physicist in the US Navy. He completed medical
school at the University of California in San Francisco (UCSF) in 1950.
From 1951 to 1953, Myron served in the Army Medical Corps during the
Korean War, with intermittent training in internal medicine at Harvard
and work at the Army Chemical Center. After two years at Tufts Medical
School in internal medicine, Myron returned to California to work as
166
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Research Associate at the Lawrence Radiation Laboratory and Donner
Laboratory in Berkeley until 1961. In 1962, he accepted the position of
Professor in Laboratory Medicine and Radiology at the UCSF School of
Medicine, where he introduced the young field of Nuclear Medicine. In
1968, he became the Director of the Nuclear Medicine Department and
Chief of Service, continuing there until his retirement in 1991. Myron, as
a Professor Emeritus, moved to the Nuclear Regulatory Commission
(NRC) in Maryland, where he was appointed to the position of Visiting
Medical Fellow.
His biomedical research began in 1951 at the US Army Chemical
Center on non-hemorrhagic fatal traumatic shock. It continued at various
places using radioactive isotopes as tracers in glucose metabolism, in
assessing the mono-carbon pool, folic acid, and vitamin B12 kinetics. It
included the application of iron-59 and chromium-51 in hematology. His
research data appeared in the most prestigious journals, and they became
internationally accepted milestones in clinical medicine. Being a boardcertified specialist in pathology and nuclear medicine, and as director of
the Clinical Laboratory at the San Francisco General Hospital, Myron was
responsible for the services of the Chemistry, Microbiology, and
Immunology Divisions. He was also clinically responsible as the Division
Chief of the Nuclear Medicine, Hematology, and the Blood Bank services. Not to be overlooked was his enthusiasm for teaching in Nuclear
Medicine, Hematology, and Clinical Pathology to medical students, residents and house officers.
Myron’s life-long clinical engagement and success, and his experience with radioactive tracers and his awareness of the associated health
risks made him, in his top academic position, an ideal candidate for advising the U.S. Nuclear Regulatory Commission (NRC) as Visiting Medical
Fellow. In 1991, he and Rosalyn, whom he had married when he was 20
years old, moved into a lovely townhouse in Maryland, close to the NRC
headquarters in Rockville. Their home became a cultural gem. As an
NRC Visiting Medical Fellow, Myron had to adjust to the workings and
goals of the NRC. He delivered his expertise in the medical use of
radioisotopes, both diagnostic and therapeutic, and he served as an effective interface between the NRC and the country’s medical organizations.
Amongst his many obligations at the NRC, Myron began immediately
to explore the experimental and epidemiological observations on effects
and risks of low doses of ionizing radiation. These initial investigations
led to the report “Positive health effects of low-level radiation in human
populations.” It was published in 1994 in the conference proceedings
“Biological Effects of Low-Level Exposures: Dose-Response
Relationships,” edited by E.J. Calabrese; Lewis Publishers, Chelsea, MI:
171-187. About a year later at a meeting on low-dose risks at the US
National Academy of Sciences, Myron and Ludwig Feinendegen met and
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they began a most fruitful collaboration producing together 14 peerreviewed papers. This collaboration continued beyond Myron’s retirement from NRC in 2005. They gave presentations, often together, at
numerous conferences and workshops. These included Jim
Muckerheide’s “Radiation, Science, and Health” meetings, which also
touched political issues.
Ludwig lived in Maryland not far from the Pollycoves. They became
close friends and also enjoyed social functions in the region and common
hobbies such as music and theater in DC and Maryland, always in the
company of Rosalyn, an accomplished pianist herself. There was no gettogether with colleagues, though, without talking and revolving at least a
bit around the best way to accommodate published data and arguments
into a pattern of mechanisms that could serve a model to describe system
responses to low doses.
One of Myron’s particular contributions was his courageous unraveling of low-dose response functions as they were published by epidemiologists on the basis of the Linear-no-Threshold (LNT) hypothesis, without
consideration not only of actual data at low doses but also of the increasing experimental evidence and epidemiological suggestions against the
validity of the LNT hypothesis and for hormetic responses to low doses.
In doing so he uncovered shortcomings by epidemiologists and statisticians in dealing with hard data.
Another particular initiative by Myron was estimating the rate of DNA
damage production from endogenous reactive oxygen species (ROS).
This project together with Ludwig was supported by the US Department
of Energy (DOE) as a potential input into formatting the DOE Low Dose
Research program that had started just then. The execution demanded
repeated group discussions with experts, also on the West Coast. It was a
great satisfaction to see their estimates fall into agreement with the experimental data reported later from different laboratories. The essential
finding was that, irrespective of quality, the average number of double
strand DNA breaks (DSBs) per day from endogenous ROS per cell was
about a thousand times higher than the respective DSB number from
average background radiation. Until then, the production rate of nonradiogenic DSB had been grossly underestimated.
This finding supported the hypothesis that adaptive protection,
induced by low-dose radiation, can significantly reduce the incidence of
non-radiogenic cancer. The hypothesis rests on what is called The Dual
Response Model. This model endeavors to describe net radiogenic cancer
induction as the difference between a) low-dose induced cancer and b)
low-dose induced protection against non-radiogenic plus radiogenic cancer, as functions of absorbed dose. It had been discussed since the early
90s in different ways, at various laboratories. The model predicts the beneficial effects of low doses as the balancing or even outweighing of detri168
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ment, and thus predicts a dose threshold for radio-oncogenesis or even a
reduction of cancer incidence below the control level.
The growing evidence of beneficial effects of low doses, i.e., hormetic responses to low doses, strengthened the repeated proposal by Myron,
with support from Jerry Cuttler and Ludwig, to attempt clinical applications of low doses in the treatment of cancer and infectious diseases, as
Kiyohiko Sakamoto had carried out in Japan in clinical studies on two
hundred cancer patients. Myron contributed this topic importantly
already, in 1998, to the Pacific Basin Nuclear Conference (PBNC) in
Banff, Canada and again to the 2004 PBNC meeting in Hawaii. The most
recent paper on this issue was delivered by Myron and Ludwig just three
years ago at the Low-Dose-Workshop in Richland, WA, in honor of Vic
Bond. Thereafter, Myron had increasing difficulties in traveling, but he
kept in touch and continued publishing. His last paper, together with
Ludwig and Ron Neumann from the NIH, appeared in 2013 and presented an updated review on radiation hormesis.
It was a happy occasion in 2010 to witness Myron receiving the prestigious Outstanding Career Achievement Award from the International
Dose Response Society, which was founded by Ed Calabrese and where
Myron contributed greatly to the publication series Biological Effects of
Low Level Exposures (BELLE).
Throughout his work and many experiences, Myron was sharp-witted
and meticulously precise in definitions, planning and execution of all he
did. And Rosalyn was always at his side and support, until overcome by
her fast-evolving illness less than 10 years ago. Eventually, the Pollycoves
returned to the Bay Area in San Francisco to be closer to their children.
Myron remained full of ideas. He had a warm-hearted approach to people and enthusiasm towards all progress for the good. He had a realistic
vision of human endeavors at all levels of life with a great capacity for tolerance, yet a stubborn resistance against what he saw as preventable
errors or misconducts – just as the compassionate classical music lover
that he was rejects orchestras that are “out-of-tune.” His ideas will live on.
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